These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 4112569

  • 21. Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet.
    Cowie RL, Brink BA.
    S Afr Med J; 1990 Apr 21; 77(8):390-1. PubMed ID: 2184527
    [Abstract] [Full Text] [Related]

  • 22. Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India.
    Tubercle; 1983 Jun 21; 64(2):73-91. PubMed ID: 6351390
    [No Abstract] [Full Text] [Related]

  • 23. A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation.
    S Afr Med J; 1996 Aug 21; 86(8):960-5. PubMed ID: 8823423
    [Abstract] [Full Text] [Related]

  • 24. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1988 May 21; 137(5):1147-50. PubMed ID: 2904237
    [Abstract] [Full Text] [Related]

  • 25. Tuberculosis treatment: dangerous regimens?
    Rieder HL, Arnadottir T, Trébucq A, Enarson DA.
    Int J Tuberc Lung Dis; 2001 Jan 21; 5(1):1-3. PubMed ID: 11263509
    [No Abstract] [Full Text] [Related]

  • 26. A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Tuberculosis Research Centre, Madras, and National Tuberculosis Institute, Bangalore.
    Am Rev Respir Dis; 1986 Jul 21; 134(1):27-33. PubMed ID: 3524334
    [Abstract] [Full Text] [Related]

  • 27. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
    Lancet; 1979 Jun 30; 1(8131):1361-3. PubMed ID: 87829
    [Abstract] [Full Text] [Related]

  • 28. Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis: first report: Third East African/British Medical Research Councils study.
    Am Rev Respir Dis; 1978 Jul 30; 118(1):39-48. PubMed ID: 79319
    [Abstract] [Full Text] [Related]

  • 29. A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.
    Tubercle; 1973 Mar 30; 54(1):23-45. PubMed ID: 4204397
    [No Abstract] [Full Text] [Related]

  • 30. General considerations in intermittent drug therapy of pulmonary tuberculosis.
    Fox W.
    Postgrad Med J; 1971 Nov 30; 47(553):729-36. PubMed ID: 4110537
    [Abstract] [Full Text] [Related]

  • 31. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
    Am Rev Respir Dis; 1984 Jun 30; 129(6):921-8. PubMed ID: 6375490
    [Abstract] [Full Text] [Related]

  • 32. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec 30; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pulmonary tuberculosis treated with isoprodian and rifampicin or pyrazinamide.
    Kleeberg HH.
    Chemotherapy; 1987 Dec 30; 33(3):219-28. PubMed ID: 3297528
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A controlled comparison of four regimens of streptomycin plus pyrazinamide in the retreatment of pulmonary tuberculosis.
    Tubercle; 1969 Jun 30; 50(2):81-114. PubMed ID: 4892324
    [No Abstract] [Full Text] [Related]

  • 37. Short-course treatment in pulmonary tuberculosis.
    Jindani A.
    East Afr Med J; 1975 Sep 30; 52(9):472-80. PubMed ID: 53135
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Rifampin-isoniazid compared with PAS-isoniazid-streptomycin in initial treatment of pulmonary tuberculosis. A controlled cooperative trial.
    Boman G.
    Chest; 1972 Jun 30; 61(6):533-8. PubMed ID: 5032151
    [No Abstract] [Full Text] [Related]

  • 40. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M.
    Kekkaku; 2001 Jan 30; 76(1):33-43. PubMed ID: 11211781
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.